Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia

Roberta Mazzarella, Laura Cicconi, Salvatore Perrone, Maria Domenica Divona, Sara Ceccolini, Anna Maria Nardozza, Annalisa Biagi, Tiziana Ottone, Andrea Corbingi, Paola Panetta, Elettra Ortu La Barbera, Luciano Fiori, Azzurra Anna Romeo, Giada Pacitto, Ettore Cotroneo, Massimo Breccia, Maria Teresa Voso, Alessandro Pulsoni

Open source

DOI: 10.1007/s00277-026-06793-9
Published: 2026-02-17
Container: Annals of Hematology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00277-026-06793-9,
  title = {Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia},
  author = {Roberta Mazzarella and Laura Cicconi and Salvatore Perrone and Maria Domenica Divona and Sara Ceccolini and Anna Maria Nardozza and Annalisa Biagi and Tiziana Ottone and Andrea Corbingi and Paola Panetta and Elettra Ortu La Barbera and Luciano Fiori and Azzurra Anna Romeo and Giada Pacitto and Ettore Cotroneo and Massimo Breccia and Maria Teresa Voso and Alessandro Pulsoni},
  year = {2026},
  journal = {Annals of Hematology},
  doi = {10.1007/s00277-026-06793-9},
  url = {https://doi.org/10.1007/s00277-026-06793-9}
}

RIS

TY  - JOUR
TI  - Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia
AU  - Roberta Mazzarella
AU  - Laura Cicconi
AU  - Salvatore Perrone
AU  - Maria Domenica Divona
AU  - Sara Ceccolini
AU  - Anna Maria Nardozza
AU  - Annalisa Biagi
AU  - Tiziana Ottone
AU  - Andrea Corbingi
AU  - Paola Panetta
AU  - Elettra Ortu La Barbera
AU  - Luciano Fiori
AU  - Azzurra Anna Romeo
AU  - Giada Pacitto
AU  - Ettore Cotroneo
AU  - Massimo Breccia
AU  - Maria Teresa Voso
AU  - Alessandro Pulsoni
PY  - 2026
JO  - Annals of Hematology
DO  - 10.1007/s00277-026-06793-9
UR  - https://doi.org/10.1007/s00277-026-06793-9
ER  -

APA

Mazzarella, R., Cicconi, L., Perrone, S., Divona, M. D., Ceccolini, S., Nardozza, A. M., Biagi, A., Ottone, T., Corbingi, A., Panetta, P., Barbera, E. O. L., Fiori, L., Romeo, A. A., Pacitto, G., Cotroneo, E., Breccia, M., Voso, M. T., & Pulsoni, A. (2026). Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-026-06793-9

Source records

crossref · retrieved 2026-11-08T14:13:37.747Z